Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Gemphire Therapeutics Inc. (GEMP)

1.1182 -0.032 (-2.77%)

11-20 14:03

Open:

1.07

Pre. Close:

1.15

High:

1.13

Low:

1.07

Volume:

66,451

Market Cap:

16M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.351 - 1.359

1.359 - 1.365

Low:

1.055 - 1.063

1.063 - 1.069

Close:

1.138 - 1.15

1.15 - 1.16

Technical analysis  (as of: 2018-11-20 1:31:52 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 1.74     One year: 2.04

Support:

Support1: 1.07    Support2: 0.89

Resistance:

Resistance1: 1.49    Resistance2: 1.75

Pivot:

1.27

Moving Averages:

MA(5): 1.20     MA(20): 1.27

MA(100): 3.22     MA(250): 5.57

MACD:

MACD(12,26): -0.14     Signal(12,26,9): -0.15

%K %D:

%K(14,3): 12.49     %D(3): 14.83

RSI:

RSI(14): 31.96

52-Week:

High: 11.43  Low: 0.832  Change(%): -87.6

Average Vol(K):

3-Month: 56394  10-Days 6901

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GEMP has closed above bottom band by 6.5%. Bollinger Bands are 86.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to GEMP's normal range. The bands have been in this narrow range for 57 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-11-08T16:55:54-05:00
Gemphire Therapeutics reports Q3 results

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

14.27

Shares Float (M)

11.10

% Held by Insiders

22.20

% Held by Institutions

38.00

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-2.110

EPS Est. Current Year

-2.980

EPS Est. Next Year

-2.620

EPS Est. Next Quarter

-0.590

Forward EPS

-3.424

Book Value (p.s.)

1.310

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-104.7

Return on Equity (ttm)

-257.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-24.56

Levered Free Cash Flow (M)

-13.34

Valuation

P/E

-0.53

P/E Growth Ratio

-0.03

P/BV

0.85

P/S

P/CF

-0.65

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.